BGI and mining box
1. Cloud health gene technology (Shanghai) Co., Ltd.
cloud health is a leading high-tech enterprise in the instry, which focuses on providing genome-wide detection and precise health medical solutions for health and clinical research
cloud health has established a complete set of genome detection technology platform, including the world's most advanced hiseq x ten ultra high throughput whole genome sequencing system and other new generation sequencing (NGS) systems, as well as microarray, qPCR, etc
Beijing Dino Gene Technology Co., Ltd.Beijing Dino Gene Technology Co., Ltd. is a biotechnology high-tech professional organization for clinical research and technology application of genomic medicine
the company has introced international advanced disease prevention and diagnosis technology and concept into China, with disease gene diagnosis, tumor indivialized treatment and detection, disease risk gene detection and health management as the main service content, and involved in the application and promotion of stem cell regeneration technology, enjoying a high reputation in the instry
3. Nucleogene
Shenzhen nucleogene Technology Co., Ltd. (hereinafter referred to as nucleogene) is a leading genomics research institution in the world; It is a biological high-tech enterprise providing professional gene detection and research services for major domestic research institutions
relying on the world's leading biotechnology, nuclear gene is a clinical medical platform established by applying human genome research results to the field of health, establishing gene detection standards, promoting the clinical application of gene technology, and committed to recing the harm of birth defects and major diseases to human health
BGI is a leading scientific and technological institution specialized in life sciences. It is a scientific research mode based on learning, research and application. It involves the research of molecular genetics in human, medicine, agriculture, animal husbandry and endangered animal protection Shenzhen paternity testing center is an organization specialized in DNA paternity testing. Shenzhen paternity testing technology relies on the judicial identification center of Shanghai Medical College of Fudan University. In the past three years, it has provided high accuracy and high density DNA paternity testing gene testing services for customers in Guangdong Province is not a lie
BGI is a leading scientific and technological institution specialized in life sciences. It is a scientific research mode based on learning, research and application. It involves the research of molecular genetics in human, medicine, agriculture, animal husbandry and endangered animal protection<
on December 18, 2015, China Securities Regulatory Commission (CSRC) announced the application draft of BGI to be listed on the gem, and the company's listed sponsor was CITIC Securities (600030)
{rrrrrrr}
extended materials:
BGI is committed to international open ecation, establishing a new ecation and training system of "projects lead disciplines, instries and talents" and training talents in actual combat, and carrying out joint training programs of undergraate, postgraate and doctoral degree with many well-known universities at home and abroad, It covers non academic ecation and public ecation, and cultivates innovative talents needed by scientific research and instry in the field of biology
vision of the organization: to build a cross domain teaching platform, provide high-quality ecation resources, cultivate biological science and instrial talents, and establish an innovative ecation system to adapt to the new life science and the future development of biological instry and bio economy
BGI has established ecational cooperation with more than 10 well-known universities including South China University of technology, Wuhan University and Southeast University, adopting the mode of "2.5 + 1.5 + X" or "3 + 1 + X" to carry out undergraate, postgraate and doctoral joint training, as well as cooperating with the Chinese University of Hong Kong, Copenhagen University, Aarhus University The University of California, Davis and other internationally renowned universities have carried out joint master and doctoral training programs to explore innovative talent training methods
BGI became the first CFDA approved non-invasive prenatal genetic testing listed company
on June 30, 2014, the State Food and Drug Administration approved bgiseq-1000 gene sequencer, bgiseq-100 gene sequencer, fetal chromosomal aneuploidy (T21, T18, T13) detection kit (combined probe anchor connection sequencing method), fetal chromosomal aneuploidy (T21, T18, T13) detection kit (combined probe anchor connection sequencing method), and fetal chromosomal aneuploidy (T21, T18, T13) T13) test kit (semiconctor sequencing) medical device registration. This is the second generation of gene sequencing diagnostic proct approved and registered by the State Food and Drug Administration for the first time
this batch of procts can be used for non-invasive prenatal examination and auxiliary diagnosis of fetal chromosomal aneuploidy diseases, including trisomy 21, trisomy 18 and trisomy 13, by sequencing the free gene fragments in the plasma of high-risk pregnant women with gestational age more than 12 weeks.
according to the data released by the health emergency office of the Ministry of health on April 6, 2013, as of 17:00, a total of 18 confirmed cases of human infection with h7n9 avian influenza have been reported in China, including 6 deaths. After the emergence of human infection with h7n9 avian influenza, BGI immediately actively contacted and participated in the research of the virus, opened the emergency channel, and established a rapid detection platform, which could accurately detect the samples within 36 hours. Moreover, the genome database of influenza and major infectious diseases has been constructed, which can timely respond to various public health emergencies. The Indian Ocean tsunami
on December 30, 2004, BGI sent a DNA identification and rescue team to the tsunami stricken area of Thailand to undertake the task of DNA detection of tsunami victims. At that time, the number of victims was so large that DNA identification could not be carried out. BGI offered to identify more than 1000 DNA samples for Thai victims free of charge
Wenchuan earthquake
from May 18 to June 2, 2008, the CDC working group of BGI earthquake stricken areas went to Sichuan disaster areas to participate in the post disaster reconstruction work of "5.12 Wenchuan earthquake" to detect possible health emergencies and infectious diseases. In May 2008, all employees of BGI donated their love to the compatriots affected by the Wenchuan earthquake
Ya'an earthquake
at 8:02 a.m. on April 20, 2013, a 7.0 magnitude earthquake occurred in Lushan County, Ya'an City, Sichuan Province. BGI announced that it will provide free technical services for the earthquake stricken areas, including epidemic monitoring, emergency pathogenic microorganism detection, identity identification, HLA matching detection for the treatment of patients, and will donate the first 100000 copies of diagnostic reagents for blood transfusion safety, pathogen detection and other applications. And coordinate all possible platform resources, do a good job in technical and personnel reserves, in a 24-hour standby state, organize science and technology rescue team to rush to the front line at any time. Provide free genetic testing for 100 patients with ichthyosis
on July 21, 2014, Shenzhen Huada gene said on July 21 that it would collect 100 qualified patients with ichthyosis from the society and provide them with free genetic testing and genetic counseling services. This plan is called Xiaoming plan< On July 8, 2014, BGI announced the launch of "ten million families away from genetic birth defects" plan in Beijing, including "Ziqi plan" for patients with mucopolysaccharidosis, "Chunshu plan" for thalassemia and "Xiaoming plan" for ichthyosis< On March 7, 2013, Huada Health launched the first "cervical care day" and the "national million women innovative cervical cancer screening project"< In 2010, BGI donated 43 million yuan to assist the Chinese bone marrow bank to complete HLA high-resolution typing and sequencing of 90000 samples. On January 25, 2011, the Red Cross Society of China awarded the Red Cross Medal, the highest honor of the Red Cross of Shenzhen Huada Gene Research Institute
